Ate associations between UA and inflammatory cytokines during episodes of human malaria. Before making these correlations, we confirmed that the cytokines we measured increase with disease severity, thus implicating them in the pathogenesis of severe malaria in our Malian study population. Previous 498-02-2 studies that measured UA CAL120 cost levels in patients with malaria tested the hypothesis that UA is an indirect marker of oxidative stress [33?5]. This is because the formation of UA from hypoxanthine and xanthine generates ROS. Only two previous studies examined the relationship between UA levels and P. falciparum densities 
in patients with malaria. Bertrand et al. [33] describe a weak correlation (r = 0.06, p.0.05) in a group of 60 Cameroonian adults with UM. In comparing groups of Nigerian children with asymptomatic parasitemia, UM and severe malaria, Iwalokun et al. [35] showed that the association between UA levels and parasite 1326631 density gets stronger with disease severity; however, this correlation (r = 0.61, p,0.05) was significant only in the group of severe cases. Our analysis of 438 Malian children with UM shows a moderate, but highly significant, correlation (r = 0.1641, p = 0.0006) between UA levels and parasite densities. Our study has several limitations. First, we are unable to identify the cause of elevated UA levels in our patients. During a malariaepisode, excess soluble UA may be produced by a variety of processes, including the dissolution of parasite-derived UA precipitates, the conversion of parasite-accumulated hypoxanthine and xanthine to UA by plasma xanthine oxidase, and the hemolysis of both parasitized and non-parasitized RBCs. The levels of UA produced by any of these processes may correlate with parasite density. More detailed studies of renal function in children with malaria are needed to determine whether subclinical renal insufficiency also helps to increase the concentration of UA in plasma. Second, we are unable to quantify the `local’ levels of parasite-derived UA in microvessels. UA and cytokine levels may be considerably higher in the post-capillary venules where schizonts rupture than in the large veins from which we obtain plasma. We are also unable to quantify the amount of parasitederived UA precipitates that may be present as un-dissolved, yet immunostimulatory, material in microvessels. Third, the correlations between UA and cytokine levels cannot definitively establish that UA is directly stimulating immune cells to produce the cytokines we measured. In support of this possibility, however, we found that UA levels correlate significantly with IL-6, TNFa and IL-10 levels. These findings are consistent with those of Orengo et al. [10,11] who found that parasite-derived UA directly stimulates human PBMCs to produce 1326631 IL-6, TNFa and IL-10 in vitro. In summary, the present study provides clear evidence that baseline UA levels increase in malaria and that UA levels correlate with the levels of multiple cytokines implicated in the pathogenesis of this disease. Confirming a role for soluble UA in causing the symptoms and complications of malaria may require clinical trials of allopurinol or uricosuric drugs as adjunctive therapies. Immunohistochemical staining of autopsy specimens, or biopsies of muscle and dermis in live patients with uncomplicated P. falciparum malaria, may provide direct proof that parasite-derived UA precipitates are localized to microvessels and in contact with immune or other host cells (e.g., en.Ate associations between UA and inflammatory cytokines during episodes of human malaria. Before making these correlations, we confirmed that the cytokines we measured increase with disease severity, thus implicating them in the pathogenesis of severe malaria in our Malian study population. Previous studies that measured UA levels in patients with malaria tested the hypothesis that UA is an indirect marker of oxidative stress [33?5]. This is because the formation of UA from hypoxanthine and xanthine generates ROS. Only two previous studies examined the relationship between UA levels and P. falciparum densities in patients with malaria. Bertrand et al. [33] describe a weak correlation (r = 0.06, p.0.05) in a group of 60 Cameroonian adults with UM. In comparing groups of Nigerian children with asymptomatic parasitemia, UM and severe malaria, Iwalokun et al. [35] showed that the association between UA levels and parasite 1326631 density gets stronger with disease severity; however, this correlation (r = 0.61, p,0.05) was significant only in the group of severe cases. Our analysis of 438 Malian children with UM shows a moderate, but highly significant, correlation (r = 0.1641, p = 0.0006) between UA levels and parasite densities. Our study has several limitations. First, we are unable to identify the cause of elevated UA levels in our patients. During a malariaepisode, excess soluble UA may be produced by a variety of processes, including the dissolution of parasite-derived UA precipitates, the conversion of parasite-accumulated hypoxanthine and xanthine to UA by plasma xanthine oxidase, and the hemolysis of both parasitized and non-parasitized RBCs. The levels of UA produced by any of 
these processes may correlate with parasite density. More detailed studies of renal function in children with malaria are needed to determine whether subclinical renal insufficiency also helps to increase the concentration of UA in plasma. Second, we are unable to quantify the `local’ levels of parasite-derived UA in microvessels. UA and cytokine levels may be considerably higher in the post-capillary venules where schizonts rupture than in the large veins from which we obtain plasma. We are also unable to quantify the amount of parasitederived UA precipitates that may be present as un-dissolved, yet immunostimulatory, material in microvessels. Third, the correlations between UA and cytokine levels cannot definitively establish that UA is directly stimulating immune cells to produce the cytokines we measured. In support of this possibility, however, we found that UA levels correlate significantly with IL-6, TNFa and IL-10 levels. These findings are consistent with those of Orengo et al. [10,11] who found that parasite-derived UA directly stimulates human PBMCs to produce 1326631 IL-6, TNFa and IL-10 in vitro. In summary, the present study provides clear evidence that baseline UA levels increase in malaria and that UA levels correlate with the levels of multiple cytokines implicated in the pathogenesis of this disease. Confirming a role for soluble UA in causing the symptoms and complications of malaria may require clinical trials of allopurinol or uricosuric drugs as adjunctive therapies. Immunohistochemical staining of autopsy specimens, or biopsies of muscle and dermis in live patients with uncomplicated P. falciparum malaria, may provide direct proof that parasite-derived UA precipitates are localized to microvessels and in contact with immune or other host cells (e.g., en.
